1. Haisco Pharmaceutical signed an exclusive licensing agreement with AbbVie Group, with potential milestone payments of up to $715 million.
2. MicroStrategy founder Michael Saylor again signaled a potential increase in Bitcoin holdings, following his previous purchasing patterns.
3. Iran stated that negotiations with the opposing side failed to gain their trust, indicating continued geopolitical tension.
Pharma Stock Jumps on $715M Deal, Saylor Hints at BTC Buy, Iran Talks Stall
